Sandbox Reserved 1092: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 61: | Line 61: | ||
During the research trials, a monoclonal antibiotic was injected to mice during 10 weeks and the results showed that the muscle strength and the muscle fiber diameter increased. Moreover, the expression of the markers of muscle fibrosis reduced. However, myostatin does not cure the disease because no change was noticed the in intra-nuclear inclusion density, which is a characteristic of OPMD spread. It is for now only a solution to treat the symptom. | During the research trials, a monoclonal antibiotic was injected to mice during 10 weeks and the results showed that the muscle strength and the muscle fiber diameter increased. Moreover, the expression of the markers of muscle fibrosis reduced. However, myostatin does not cure the disease because no change was noticed the in intra-nuclear inclusion density, which is a characteristic of OPMD spread. It is for now only a solution to treat the symptom. | ||
In other cases, it is also possible to introduce follistatin <ref> PMID:19644449</ref> to block myostatin because they will form a complex which will stop the myostatin' action. | In other cases, it is also possible to introduce follistatin <ref> PMID:19644449</ref> to block myostatin because they will form a complex which will stop the myostatin' action. | ||
== References == | == References == | ||
<references/> | <references/> | ||
</StructureSection> | </StructureSection> | ||
